Adcetris Interactions
There are 656 drugs known to interact with Adcetris (brentuximab), along with 8 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 67 are major, and 589 are moderate.
- View all 656 medications that may interact with Adcetris
- View Adcetris alcohol/food interactions (2)
- View Adcetris disease interactions (8)
Most frequently checked interactions
View interaction reports for Adcetris (brentuximab) and the medicines listed below.
- Adcirca (tadalafil)
- Adriamycin (doxorubicin)
- bleomycin
- Blincyto (blinatumomab)
- Braftovi (encorafenib)
- Celebrex (celecoxib)
- CellCept (mycophenolate mofetil)
- Corlanor (ivabradine)
- Cosentyx (secukinumab)
- Cymbalta (duloxetine)
- Cytoxan (cyclophosphamide)
- Emgality (galcanezumab)
- Empliciti (elotuzumab)
- enalapril
- Entyvio (vedolizumab)
- Esbriet (pirfenidone)
- Hemlibra (emicizumab)
- Idhifa (enasidenib)
- Imbruvica (ibrutinib)
- Kalydeco (ivacaftor)
- Kynamro (mipomersen)
- Letairis (ambrisentan)
- Ocrevus (ocrelizumab)
- Ofev (nintedanib)
- Oncovin (vincristine)
- prednisone
- Ravicti (glycerol phenylbutyrate)
- Repatha (evolocumab)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- Tecfidera (dimethyl fumarate)
Adcetris alcohol/food interactions
There are 2 alcohol/food interactions with Adcetris (brentuximab).
Adcetris disease interactions
There are 8 disease interactions with Adcetris (brentuximab) which include:
- infections
- tumor lysis syndrome
- hepatotoxicity
- hyperglycemia
- peripheral neuropathy
- pulmonary toxicity
- renal impairment
- Brentuximab vedotin -GI events
Report options
QR code containing a link to this page
More about Adcetris (brentuximab)
- Adcetris consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CD30 monoclonal antibodies
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.